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Abstract
Background: Staphylococcus aureus is a notorious human pathogen that causes often lethal systemic conditions that
are mostly medical device associated biofilm infections. Similarly, coagulase negative staphylococci are emerging as
leading pathogen for nosocomial infections owing to their ability to form biofilm on implanted medical equipment.
Chronic in nature, these infections are difficult to treat. Such recalcitrance of these infections is caused mainly due to
the presence of persister cells, which exhibit transient yet extreme tolerance to antibiotics. Despite tremendous clinical significance, there is lack of studies on persister cells formation among clinical bacterial isolates. Considering the
importance of factors influencing persister formation, in this study, we evaluate the association of antibiotic tolerance
with biofilm production, antibiotic stress, growth phase, specimen type, and dependency on staphylococcal species. Biofilm formation was detected among 375 clinical staphylococcal isolates by quantitative tissue culture plate
method (TCP) and icaAD genes by genotypic method. The antibiotic susceptibility was determined by Kirby Bauer
disc diffusion method while minimum inhibitory concentration values were obtained by agar dilution method. Persister cells were measured in the susceptible staphylococcal isolates in the presence of clinically relevant antibiotics.
Results: In the study, 161 (43%) S. aureus and 214 (57%) coagulase negative staphylococci (CNS) were isolated from
different clinical samples. TCP method detected biofilm production in 84 (52.2%) S. aureus and 90 (42.1%) CNS isolates.
The genotypic method detected icaAD genes in 86 (22.9%) isolates. Majority (> 90%) of both the biofilm producers
and non-producers were sensitive to chloramphenicol and tetracycline but were resistant to penicillin. Interestingly, all isolates were sensitive to vancomycin irrespective of biofilm production. While high persister frequency was
observed among all staphylococci isolates in the stationary growth phase, the persister frequency in exponential
growth phase was statistically high among isolates possessing icaAD genes compared to icaAD negative isolates.
Conclusion: The research findings provide strong evidence that the clinical staphylococcal isolates exhibit extreme
antibiotic tolerance suggesting their causal link with treatment failures. Understanding the factors influencing the
formation and maintenance of persister cells are of utmost important aspect to design therapeutics and control recalcitrant bacterial infections.
Keywords: Biofilm, Persister cells, Clinical staphylococcal isolates, icaAD genes
Background
Persister cells represent a bacterial subpopulation that
exhibits transient non-growing state accompanied by
transient yet extreme antibiotic tolerance. In 1944,
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Bigger discovered and coined the term “persister cells” to
represent a small fraction of Staphylococcus aureus cells
that could not be killed by lethal concentration of penicillin [1]. Since last decade, increasing number of studies
has highlighted the clinical significance of persister cells
in major bacterial pathogens including S. aureus and
coagulase negative staphylococci (CNS). Persisters during in vitro antibiotic treatment display a characteristic
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biphasic killing curve as majority of the susceptible cells
are rapidly killed on exposure to high concentration of
antibiotics while small proportion survives for extended
time [2, 3]. Upon removal of the antibiotic stress, however, persisters resume their growth and form a population that is identical to the original population in genetic
diversity [4] and constituting similar fractions of antibiotic tolerant population [5]. Contrary to the development of antibiotic resistance, antibiotic tolerance in
bacteria occurs without any genetic mutation [6]. Due
to their ability to regrow when treatment is ceased, persister cells can cause the relapse of bacterial infections
[7, 8]. This phenomenon, therefore, posits for a paradox
that antibiotic susceptible bacteria are the major cause
of treatment failures. Besides, persisters are also considered as an important arsenal of bacterial pathogens
that allow for their adaptation in stressful environment
subsequently increasing the risk of developing antibiotic
resistance during treatment [9].
Despite plethora of studies, the mechanisms underlying the persister phenomenon is not yet conclusive. The
involvement of stringent response and dormancy were
widely recognized as underlying factors for persister formation; however, recent studies have challenged these
findings [7, 10–12]. Therefore, the persistence remains
an elusive bacterial phenomenon. Nonetheless, a recent
study depicts a clinical relevance of treatment failures
of S. aureus by demonstrating the occurrence of persister switch intracellularly in response to an antibiotic
stress [13]. Likewise, high persister phenotype was also
observed in clinical S. aureus isolates suggesting their
importance in treatment management [14].
S. aureus is a notorious human pathogen that can
cause minor skin infections to systemic diseases including infective endocarditis, osteomyelitis and bacteraemia [15]. CNS being the normal commensal of skin and
anterior nares have long been considered as non-pathogenic and rarely reported to cause severe infection.
However, as a result of the increased use of intravascular devices as treatment as well as increased number of immune compromised patients, CNS has been
emerged as a major cause of nosocomial infections [16].
These are mostly biofilm associated infections caused
due to the contaminated indwelling devices such as
catheters, prostheses, and heart valves that are highly
prevalent among health care settings and impose high
socio-economic burden worldwide [17]. Bacterial biofilms, which are micro-colonies encased in extracellular
polysaccharide material, mediated by gene products of
the icaADBC operon, are the sources of many bacterial infections which hardly respond to routine treatments. The icaADBC encodes four genes including
icaA, icaB, icaC, and icaD, which collectively produce
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polysaccharide intercellular adhesin (PIA), facilitate
the cells binding together and forming into biofilms
[18]. Due to physiological stresses resulting through
nutrition depletion and oxygen limitation [19], biofilms
favour the generation of antibiotic tolerant persister
cells, thereby facilitates the recalcitrance of infections
[20, 21]. According to the Center for Disease Control
and Prevention (CDC), majority of the infections are
associated with biofilms formed by S. aureus, S. epidermidis and Pseudomonas aeruginosa [22, 23]. Therefore, given their contribution in persister generation
and subsequent refractory infections, understanding
the mechanisms to eradicate biofilms would be a highly
remarkable strategy to minimize the risk of treatment
failures.
Antibiotic resistance is widespread and imposes
a high socio-economic burden. Studies so far have
reported high prevalence of antibiotic resistance especially in staphylococcal infections in Nepal [24–28].
In a recent report, we showed the association of biofilm production and antibiotic resistance in the clinical
staphylococcal isolates collected in tertiary care hospitals in Nepal [29, 30]. Majority of the isolates (80%)
were methicillin resistant S. aureus (MRSA) isolates
whereas all the isolates were susceptible towards vancomycin. Similarly, almost all the isolates were sensitive
towards chloramphenicol and tetracycline (97% and
94%). Likewise, more than 67% isolates were also found
to be gentamycin sensitive. Despite high clinical significance of persister cells in treatment failures, there is
lack of in vitro persister study among S. aureus clinical
isolates. Given the tremendous importance of antibiotic
tolerance and treatment failures, we have investigated
the association between persister cells with their plausible determinants: biofilm, antibiotic stress, specimen
type (device associated vs others systemic infections)
and staphylococcal species (S. aureus vs coagulase negative staphylococci, CNS). The antibiotic susceptible
staphylococcal isolates that were found to produce in
vitro biofilms (strong, moderate, weak) by tissue culture
plate (TCP) method were randomly selected to measure the persister frequency. Altogether, we tested 60
staphylococcal clinical isolates that comprised ten isolates susceptible to each of the six antibiotics representing different classes of antibiotics: oxacillin, penicillin,
vancomycin (ß-lactams), gentamycin (aminoglycoside),
ciprofloxacin (fluoroquinolone), and cotrimoxazole.
To exclude any possible discrepancy and bias, antibiotic tolerance was measured until 72 h post exposure
irrespective of the growth phase or antibiotic used in
all the isolates tested. This is the first study in Nepal
that investigates the antibiotic tolerance in the clinical
staphylococcal isolates.
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Results
Distribution of staphylococcal species among clinical
specimens

In our previous study, we identified 375 staphylococcal
isolates in different clinical specimens received in the
Microbiology laboratory of two tertiary care hospitals
of Nepal. Among these, we identified 161 (43%) isolates
as S. aureus and 214 (57%) isolates as CNS [30]. Half
(n = 191, 50.9%) of the isolates were from wound/pus
specimens followed by blood (n = 90, 24%), urine (n = 24,
6.4%), and tips (n = 79, 21.1%) (Fig. S1). Likewise, most
of the S. aureus were isolated from wound/pus (n = 135,
36%) specimens whereas lesser number of S. aureus
isolates were identified in CVC tip (n = 9, 2.4%), blood
(n = 9, 2.1%), catheter tip (n = 5, 1.3%) and none from
suction tip, endotracheal tube tip (ET) and urine. Unlike
S. aureus, most of the CNS were identified from blood
(n = 82, 21.9%) followed by wound/pus (n = 56, 14.9%),
catheter tip (n = 25, 6.7%), urine (n = 24, 6.4%), and CVC
tip (n = 20, 5.3%) (Fig. S1).
Determination of antibiotic susceptibility profile
and minimum inhibitory concentration (MIC)
of staphylococcal isolates

Clinically relevant nine different antibiotics belonging to various classes were tested for susceptibility profile via disc diffusion assay. The biofilm productions
in these isolates were detected by tissue culture plate
method (TCP)—a phenotypic assay, and by detecting
icaAD genes—a genotypic screening. The results showed
that majority of the biofilm producing isolates detected
by TCP method were sensitive towards chloramphenicol (94.8%) followed by tetracycline (92%), clindamycin (79.9%), gentamycin (73.6%) and the least number
of isolates being susceptible towards penicillin (8.0%).
Similar trend of susceptibility was observed in biofilm

non-producing isolates (Table 1). Interestingly, the icaAD
positive isolates also showed similar susceptibility profile
such as majority of these isolates were sensitive towards
chloramphenicol (94.2%) followed by tetracycline (93%)
and clindamycin (86%). Likewise, icaAD negative isolates
also showed similar trend of the susceptibility towards
different antibiotics (Table 1).
Disc diffusion assay was used to test the antibiotic susceptibility profile of biofilm producing and non-producing isolates.
In our previous study [29], while detecting biofilms,
the findings from TCP method best correlated with the
icaAD genes. The TCP method detected biofilm production in 84 (52.2%) S. aureus and 90 (42.1%) CNS isolates, while the PCR detected icaAD genes in 86 (22.9%)
staphylococcal isolates suggesting their ability to produce
biofilms [29]. Furthermore on evaluation of the antibiotic resistance, biofilm producing isolates were found to
be resistant towards more number of antibiotics tested
indicating association of biofilms with increased antibiotic resistance in the staphylococcal isolates [30]. Herein,
we report the MIC values of both biofilm producers and
non-producers (Tables 2 and 3).
Dependence between persister frequency, growth phase
and antibiotic stress

The persister frequency among biofilm forming clinical
staphylococci isolates were examined in the presence
of clinically relevant antibiotics representing different
classes. As expected, in the stationary growth phase
of bacteria, we observed high persister frequency in
almost all the isolates irrespective of antibiotic used
(Fig. 1 b, d, f, h, j and l). One clinical isolate (S325)
surprisingly failed to form persisters in the presence
of vancomycin (Fig. 1d). Considering growth phase
dependency of persister fraction, we next sought to

Table 1 Antibiotic susceptibility profile of biofilm producing staphylococcal isolates by disc diffusion method
Antibiotics

Biofilm producer
(n = 174)

Biofilm non producer
(n = 201)

icaAD positive
(n = 86)

Susceptible

Susceptible

Susceptible

Resistant

Resistant

icaAD negative
(n = 289)
Resistant

Susceptible

Resistant

Cotrimoxazole

94 (54.0%)

80 (46.0%)

111 (55.2%)

90 (44.8%)

48 (55.8%)

38 (44.2%)

132 (45.7%)

157 (54.3%)

Erythromycin

46 (26.4%)

128 (73.6%)

47 (23.4%)

154 (76.6%)

32 (37.2%)

54 (62.8%)

61 (21.1%)

228 (78.9%)

Chloramphenicol

165 (94.8%)

9 (5.2%)

187 (93.0%)

14 (7.0%)

81 (94.2%)

5 (5.8%)

271 (93.8%)

18 (6.2%)

Tetracycline

160 (92.9%)

14 (8.0%)

179 (89.1%)

22 (10.9%)

80 (93.0%)

6 (7.0%)

259 (89.6%)

30 (10.4%)

Clindamycin

139 (79.9%)

35 (20.1%)

157 (78.1%)

44 (21.9%)

74 (86.0%)

12 (14.0%)

222 (76.8%)

67 (23.2%)

Penicillin

14 (8.0%)

160 (92.0%)

12 (6.0%)

189 (94.0%)

6 (7.0%)

80 (93.0%)

20 (6.9%)

269 (93.1%)

Ciprofloxacin

89 (51.1%)

85 (48.9%)

91 (45.3%)

110 (54.7%)

42 (48.8%)

44 (51.2%)

138 (47.8%)

151 (52.2%)

Cefoxitin

46 (26.4%)

128 (73.6%)

55 (27.4%)

146 (72.6%)

29 (33.7%)

57 (66.3%)

72 (24.9%)

217 (75.1%)

Gentamicin

128 (73.6%)

48 (26.4%)

135 (67.2%)

66 (32.8%)

58 (67.4%)

28 (32.6%)

205 (70.9%)

84 (29.1%)
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Table 2 Minimum inhibitory concentration (MIC) values of biofilm forming and non-forming isolates as detected by TCP method
Antibiotics

Biofilm

Antibiotics
P value

Biofilm

Positive
(n = 86)

Negative
(n = 289)

0.125–64

0.125–64

 MIC50

1

1

 MIC50

 MIC90

64

64

 MIC90

2

8

65 (37.4%)

93 (46.3%)

8 (4.6%)

22 (10.9%)

Oxacillin
Range

% resistance

Negative
(n = 289)

0.125–8

0.125–8

0.5

0.5

Range

*

% resistance

0.125–8

0.125–8

0.125–1024

0.125–1024

2

2

 MIC50

0.125

0.125

 MIC90

4

4

 MIC90

256

128

-

-

32 (18.4%)

36 (17.9%)

Range

*

Cotrimoxazole
Range

% resistance

0.5/9.5–16/304

0.5/9.5–16/304

0.125–8

0.125–8

2/38

16

 MIC50

0.25

0.5

 MIC90

16/304

512

 MIC90

8

4

78 (44.8%)

76 (37.8%)

132 (75.9%)

163 (81.1%)

Range

0.125–256

0.125–256

8

8

0.265

Erythromycin
Range
 MIC50
 MIC90
% resistance

% resistance

0.125–1024

0.125–1024

16

64

1024

1024

102 (58.6%)

139 (69.2%)

Range
 MIC50
 MIC90
0.375

% resistance

128

128

104 (59.8%)

115 (57.2%)

0.985

Gentamicin
0.125–32

1–32

0.125–128

0.125–128

 MIC50

4

4

 MIC50

1

2

 MIC90

8

8

 MIC90

64

64

7 (4.0%)

12 (6.0%)

81 (46.6%)

98 (48.8%)

% resistance

0.017

Ciprofloxacin

Chloramphenicol
Range

0.479

Penicillin

 MIC50
% resistance

0.076

Clindamycin

 MIC50
% resistance

P value

Tetracycline

Vancomycin
Range

Positive
(n = 86)

Range

0.028

% resistance

0.225

The MICs values of the isolates were determined by the agar dilution method. The sensitivity towards each antibiotic was compared between biofilm forming and
non-forming isolates. The Chi-square test was used to evaluate the statistical significance of differences in the results. The p value of < 0.05 was considered statistically
significant.
*The resistant range of MIC values of oxacillin and vancomycin is different for S. aureus and CNS. For this reason, p value is not mentioned in the table. The sensitivity
of oxacillin (n = 45, 58.4%) in biofilm producers (n = 77) vs sensitivity (n = 38, 45.2%) in biofilm non-producers S. aureus was not significantly different (p = 0.542).
Whereas the sensitivity of oxacillin (n = 76, 84.4%) in biofilm producers vs. sensitivity (n = 96, 77.4%) in biofilm non-producers CNS were significantly different
(p = 0.086). Irrespective of whether biofilm producers or not, all the isolates were vancomycin susceptible (Supplementary Table 1).

examine persister frequency in the exponential growth
phase. Although, persister cells were formed during
exponential phase, the fraction was lesser as compared
to the stationary phase in all antibiotic treatment.
Moreover, several staphylococcal isolates against each
of the antibiotic stress were defective in persister cells.
For instance, three isolates, in the presence of oxacillin (S82, S154, and S234) and vancomycin (S104, S179
and S288) did not form persister cells (Fig. 1a and c).
Surprisingly, ciprofloxacin did not eradicate any perister cells in all isolates tested (Fig. 1g and h). Likewise,
only a single isolate (S71) failed to form persister in the
presence of penicillin (Fig. 1e). Interestingly, all exponentially grown isolates were eradicated within 72 h

post-exposure of cotrimoxazole (Fig. 1i). Among those
eradicated by cotrimoxazole, one isolate (S156) formed
persister in the presence of oxacillin (Fig. 1a and b),
while another isolate (S54) failed to form persister in
the presence of gentamycin (Fig. 1k).
Altogether, our results showed that the persister phenomenon was observed in both S. aureus and CNS.
However, it is surprising that, each antibiotic tested
could eradicate the persister cells in these staphylococcal isolates. While the deterministic mechanism behind
the persister formation and killing remain unclear, the
varying effects of persister killing in our study suggest
that the type of antibiotic stress largely influence the
persister fraction.
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Table 3 Minimum inhibitory concentration (MIC) values of biofilm forming and non-forming isolates as detected by possession of
icaAD genes
Antibiotics

icaAD

Antibiotics
P value

icaAD

Positive
(n = 86)

Negative
(n = 289)

0.125- > 32

0.125- > 32

 MIC50

2

1

 MIC50

 MIC90

> 32

32

 MIC90

1

2

44.6%

37.2%

-

-

Oxacillin
Range

% resistance

Negative
(n = 289)

0.125- > 4

0.125- > 4

0.5

0.5

Range

*

% resistance

0.125- > 4

0.125- > 4

0.125- > 512

0.125- > 512

1

2

 MIC50

0.125

0.125

 MIC90

2

4

 MIC90

8

128

-

-

10.5%

14.5%

Range

*

Cotrimoxazole
Range

% resistance

0.5/9.5- > 16/304

0.5/9.5- > 16/304

0.125- > 8

0.125- > 8

0.5/9.5

16

 MIC50

0.25

0.5

 MIC90

16/304

> 16/304

 MIC90

2

2

32.6%

42.9%

-

-

Range

0.045

Erythromycin
Range

% resistance

0.125- > 512

0.125- > 512

0.125–520

0.125–520

32

32

 MIC50

8

4

 MIC90

512

> 512

 MIC90

64

128

59.3%

63.3%

46.5%

24.9%

Range

0.003

Chloramphenicol
Range

% resistance

0.015

Gentamicin
0.125- > 16

1- > 16

0.125- > 64

0.125- > 64

 MIC50

4

4

 MIC50

1

1

 MIC90

8

8

 MIC90

64

64

3.8%

2.3%

23.3%

26.6%

% resistance

0.023

Ciprofloxacin

 MIC50
% resistance

0.069

Penicillin

 MIC50
% resistance

0.217

Clindamycin

 MIC50
% resistance

P value

Tetracycline

Vancomycin
Range

Positive
(n = 86)

Range

0.516

% resistance

0.231

The MICs values of were determined by the agar dilution method. The sensitivity towards the antibiotics was evaluated among biofilm forming and non-forming
isolates based on icaAD genes. The Chi-square test was performed to see the association between MIC value and biofilm formation ability taking P < 0.05 statistically
significant.
*The resistant range of MIC values of oxacillin and vancomycin is different for S. aureus and CNS. For this reason, p value is not mentioned in the table. The sensitivity
of oxacillin (n = 20, 44.4%) in biofilm producers (n = 45) vs sensitivity (n = 63, 54.3%) in biofilm non-producers S. aureus was significantly different (p = 0.006). Likewise,
the sensitivity of oxacillin (n = 30, 73.2%) in biofilm producers (n = 41) vs sensitivity (n = 142, 82.1%) in biofilm non-producers (n = 173) CNS were significantly different
(p = 0.012). Irrespective of whether biofilm producers or not, all the isolates were sensitive towards vancomycin (Supplementary Table 2).

Persister frequency dependent on biofilm production
(icaAD genes)

Staphylococcal systemic infections are often caused by
device associated biofilms that harbour antibiotic tolerant persister cells. Considering the widespread burden
due to the recalcitrance of these infections, we next
evaluated the persister fraction based on in vitro biofilm production. More than half (51%) of the biofilm
forming isolates (as detected by phenotypic TCP assay)
formed persister cells in planktonic condition. Further,
to evaluate the involvement of icaAD genes in persister
formation, we compared persister frequency between
isolates harbouring icaAD genes with icaAD negative
isolates. Interestingly, we observed higher number of

icaAD positive isolates formed persister cells as compared to the icaAD negative isolates (Fig. 2a), which
was statistically significant (p < 0.01), suggesting that
icaAD gene may determine the formation of persister
cells. Next, we evaluated whether the nature of biofilm
(robust or weak) influences the persister formation in
these clinical isolates. Among these, only 13 (46.42%)
isolates that produced strong biofilm formed persisters. Similarly, 10 (55.5%) among moderate and 25
(46.2%) among weak biofilm producing isolates formed
persisters. These results suggest that persister formation in clinical staphylococcal isolates is likely to occur
irrespective of the nature of biofilm (robust vs weak,
p = 0.78) detected in vitro assays.
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Fig. 1 Measurement of persister cells in clinical staphylococcal isolates. Cells grown to exponential phase (a, c, e, g, i and k) and stationary growth
phase (b, d, f, h, j and l) were exposed to each antibiotic (20 × MIC for exponential and for stationary growth phase). At designated time points,
cells were harvested, washed with PBS and plated for the CFUs count after 24 h of incubation. Data represent the average of three independent
experiments. (CNS: S17, S21, S31, S44, S47, S48, S50, S53, S54, S55, S63, S71, S75, S94, S104, S107, S119, S129, S154, S155, S163, S179, S212, S214; S.
aureus: S8, S9, S23, S33, S37, S64, S82, S110, S113, S114, S124, S148, S156, S161, S166, S170, S234, S264, S288, S325).

Persister frequency dependent on antibiotic stress

Studies on antibiotic persistence mostly use antibiotics
that are clinically relevant for pathogen. In this study, to
examine whether persister formation depends on antibiotic stress, we used ten antibiotics (belonging to different classes) that have been used to treat staphylococcal
infections. Ten clinical isolates that were sensitive to
particular antibiotic were tested for persister generation.
In these tests, we observed no persister formation in the
presence of cotrimoxazole, chloramphenicol and erythromycin. Persister formation was observed in more than
half isolates in the presence of vancomycin, oxacillin,
ciprofloxacin and penicillin. Gentamycin stress on the

other hand produced persister in less number of isolates
(Fig. 2b).
Persister frequency dependent on the type of clinical
specimens

The staphylococcal systemic infections characteristically
are refractory to the antibiotic treatment. Such recalcitrance is mainly due to the biofilm that mostly harbors
antibiotic tolerant bacterial population. Considering this
nature of staphylococcal infections in treatment failures,
we sought to evaluate whether the persister frequency is
influenced by the specimen type of the clinical isolates.
We classified all the isolates from devices (catheters,
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Fig. 2 Evaluation of persister frequency on different parameters. a Comparison of percentage of persister forming isolates in biofilm producing
and non-producing isolates. Persister cells were formed by 51% of TCP positive isolates, while 60% of persister forming isolates was icaAD positive,
which is statistically different than that of icaAD negative isolates. b Persister frequency dependency on antibiotic stress used. c Persister frequency
on device (catheter, CVC, stent) associated isolates and other specimens (blood, urine, wound/pus). d Staphylococcal species (S. aureus vs CNS).
The Chi-square test was used to evaluate the statistical significance of differences in the results. The p value of < 0.05 was considered statistically
significant

CVC, stent, tips) as medical device associated and those
isolated from blood, wound /pus, urine as the other specimen. And evaluation of the results showed no significant
difference (p < 0.8) in persister formation between device
associated staphylococcal isolates with that of other specimens (Fig. 2d). These observations led to an insight that
the staphylococcal systemic infections are refractory to
the antibiotic treatment irrespective of whether they are
device associated biofilm infection or not.
Persister frequency dependent on the staphylococcal
species

Even though CNS also causes biofilm associated infection, almost all persister studies so far have focused
on the S. aureus. Moreover, in our previous study, we
observed high prevalence of antibiotic resistance in CNS
[30]. These observations led us to evaluate persister forming ability in CNS as compared to S. aureus and determine the persister formation. Interestingly, the results
showed similar persister frequency (number of persister

positive isolates among total isolates tested) in S. aureus
and CNS isolates (p = 0.54) suggesting the involvement of
CNS in treatment failures (Fig. 2c).

Discussion
In the absence of antibiotic resistance, antibiotic tolerance largely causes the treatment failures of bacterial
infections. Due to their importance in public health,
large number of study has conducted to understand the
mechanism underlying their formation and killing. However, the majority of studies have been conducted using
laboratory strains. Lack of studies on clinical isolates has
limited our understanding about the persister cells during infections. Therefore, in the present study, we aimed
to understand the role of different factors including antibiotic stress, growth phase, species and specimen types
in persister formation frequency. Owing to the importance of biofilm in persister tolerance, we also compared
the association between biofilm forming ability of clinical
staphylococcal isolates and persister formation. In vitro
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experiments show increased persister population as the
culture enters the stationary phase [31]. However, small
fractions of the persister also form in exponential phase
so we examined in vitro persister formation in both
growth phases of the staphylococcal clinical isolates. To
avoid possible interference due to the growth condition
of culture, we employed the most widely used persister
measurement method in our study. We started the culture with frozen inoculum and standardized the initial
culture for both exponential and stationary phase (see
method). The cells were grown in 5 ml broth in 50 ml
tubes (1:10 of culture-flask ratio) with continuous aeration (shaking at 225 rpm). Moreover, to examine the
biphasic killing curves, we counted the CFUs until 72 h
post exposure of antibiotics in both exponential and stationary growth phases.
Consistent with the general phenomenon of persister
cells, we observed lesser frequency of antibiotic tolerance
in exponentially grown cells as compared to the stationary phase cells, supporting the idea that mechanisms of
persister formation in clinical isolates varies dependent
on the growth phases. In each bacterial population, persister formation inversely corresponds with the cellular
energy state [31–33]. Apparently, decreased persister
fraction in exponential growth phase indicates higher
energy state of growing cells, while extreme tolerance in
stationary phase is due to their low energy state since the
killing efficiency of bactericidal antibiotics depends on
the active target. Extremely tolerant persister cells are
formed in the stationary growth phase characterized by a
nutrient depletion that exerts stress to the bacterial cells
[31]. This environment emulates the chronic bacterial
infection especially associated with the biofilms. Given
that the depletion of energy generating TCA enzymes
and ATP in a growing population determines switch into
persister [31, 32], studies so far have shown formation
of persister cells in exponentially grown bacterial pathogens as well including S. aureus, E. coli and P. aeruginosa.
Interestingly, in this study, we observed eradication of
40% of staphylococcal isolates in the exponential growth
phase. Considering the stochastic depletion of energy
in growing population [32], a universal phenomenon,
our results indicate a different mechanism of persister
formation in exponentially grown clinical staphylococcal isolates. In a recent study, the dependency of energy
state was ruled out as the increased persister fraction in
S. aureus belongs to the clonal complex 30 (CC30) clone
as compared to the CC clones was not associated with
decreased ATP content. Rather, it showed a reduced
membrane potential as a causal link for the increased
persister frequency [14]. Due to the limitation of our
study, it remains unclear whether membrane potential
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influences the degree of antibiotic tolerance in these isolates. This study, nonetheless, shows clinical staphylococcal isolates produce high frequency of persister cells
in the planktonic condition irrespective of the growth
phases.
Biofilm harbour bacterial population that are extremely
tolerant to antibiotics. In this study, more than 50% of
biofilm producing isolates as detected with phenotypic
assays formed persister cells. More interestingly, significantly higher (p < 0.01) number of icaAD positive isolates
were found to form persister cells as compared to icaAD
negative isolates, suggesting that icaAD gene may be a
predictable factor for persister generation. These findings altogether suggest that the in vitro biofilm detection
could be an important preliminary strategy to speculate
the possibility of treatment failures in the absence of
antibiotic resistance. Since there is lack of studies of persister phenomenon in clinical isolates, further studies are
needed to understand the importance of biofilm detection and its relation to the antibiotic failure due to the
persistence of isolates towards antibiotics.
Bactericidal antibiotics kill the cells by disrupting their
target; a killing mechanism that requires cellular energy.
In slow growing stationary state cells, antibiotics cannot
act on the target due to reduced energy level [2, 3]. Our
observations demonstrate that stationary state cells are
indeed extremely tolerant towards the clinically relevant
antibiotics. Our observations in all strains, albeit different degree of antibiotic tolerance, nonetheless, demonstrate that stationary state cells indeed are extremely
tolerant irrespective of the antibiotics used. In contrary,
the antibiotic tolerance of exponentially growing cells
appears to depend on the class of antibiotic used. In
the present study, all exponentially grown isolates were
killed by cotrimoxazole suggesting the possibility that
either the persister cells are formed as a response to a
stress exerted by an antibiotic or it depends on the killing
mechanism of the antibiotics. If either of these factors is
true then, the antibiotic tolerance should have been same
for all isolates to a specific antibiotic, which is not the
case as we observed different fraction although all cells
were killed. All these observations indicate the possibility of yet unidentified genetic determinants that are likely
to contribute for the persister formation irrespective of
growth phase or antibiotics used. Moreover, these findings also demonstrate that persister phenomenon may
not be solely dependent on the energy level of bacterial
cells specifically in the clinical staphylococcal isolates.
Our results infer towards the possibility that the choice
of drug is important in curing the staphylococcal infections. Although, there is possibility that the in vitro and
in vivo factors influence the persister frequency, it was
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apparently observed that the persister formation was
dependent on the class of drug used. These results suggest the possibility of specific stress from a drug could
also determine the persister formation.

Conclusions
This study demonstrated the presence of persister cells at
high concentrations in stationary cultures. Even though,
high persister frequency was observed in isolates with
icaAD genes, persister was independent of species and
type of specimen from which it was isolated. Given that
the measurement of persister against antibiotic stress is
universally used method and considering the importance
of persister in treatment failures, choice of drug would be
a good practice to cure recurring infections especially in
the absence of antibiotic resistance. All these results indicate the possibility of other unidentified determinants
that trigger the persister formation in the clinical staphylococcal isolates.
Methods
Bacterial isolates

A total of 375 clinical staphylococcal isolates were collected from two tertiary care hospitals in Nepal. Staphylococci were isolated from various clinical samples and
were identified to the species level of both coagulase
positive and negative isolates following the standard
guidelines as previously described [34]. The staphylococcal species were isolated from different clinical infections
including wound/pus, blood, urine and various used tips.
In‑vitro assay for biofilm production

We employed the tissue culture plate (TCP), a quantitative assay that is widely used and considered as the
standard for biofilm formation detection as previously
described [29, 35]. Bacterial cells from fresh culture
were inoculated in tryptic soy broth (TSB) with 1% glucose and incubated for 24 h at 37 °C in stationary condition. After incubation, the culture was diluted (1:100)
with fresh TSB medium. From this diluted culture,
0.2 ml was inoculated onto individual wells of sterile,
polystyrene, flat bottom tissue culture plates (Tarson,
India). TSB without bacterial cells served as negative
control to check the sterility and non-specific binding of
media. Further, the tissue culture plates were incubated
for 24 h at 37 °C. After incubation, the content of each
well was gently removed by pipetting slowly and tapping
the plates. The wells were washed four times with PBS
(pH 7.3) to remove the free-floating planktonic bacteria
and air dried. The biofilm cells were then fixed with 2%
sodium acetate for 5 min and stained with 1% of crystal
violet for 15 min, rinsed thoroughly and repeatedly with
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deionized water. Optical density (OD) of stained adherent bacteria was determined with a micro ELISA auto
reader by taking the absorbance at O
 D630nm [30]. Experiments for each isolate were performed in triplicates and
repeated three times. Biofilm production was categorized
as negative, weak and high depending on the OD values
of adherent cells such as OD value < 0.120 as negative,
those with OD > 0.120 and < 0.240 were regarded as weak
biofilm-producers. An OD value > 0.240 was indicative of
high biofilm-producing bacterial isolates [36].
Detection of ica genes

The genomic DNA from each isolate was extracted using
the DNA extraction Kit (Thermo Fisher), following the
manufacturer’s instruction. The sequences of intercellular adhesion (ica) genes icaA and icaD (accession number U43366) were taken from the GenBank sequence
of the National Center for Biotechnology Information
(NCBI) database. Primers specific for icaA and icaD
were designed by the Primer3 program and were purchased from Solis Biodyne, (Denmark). The primer used
for the detection of icaA was forward 5’-TCTCTTGCA
GGAGCAATCAA-3’ and reverse 5’-TCAGGCACT
AACATCCAGCA-3’ primer. The two primers include a
188-bp region. For detection of icaD, 5’- ATGGTCAAG
CCCAGACAGAG-3’ was used as a forward primer and
5’-CGTGTTTTCAACATTTAATGCAA-3’ was used as a
reverse primer with the product size of 198 bp [30].
Antibiotic susceptibility profile

Antimicrobial susceptibility tests of the isolates were carried out by the disk diffusion method using Mueller–Hinton agar plates. The bacterial suspension maintained to
0.5 McFarland standard was used to inoculate Mueller–
Hinton agar plates by swabbing them with a sterile cotton
swab. Nine different antimicrobial discs (penicillin, tetracycline, clindamycin, chloramphenicol, cefoxitin, erythromycin, cotrimoxazole, gentamycin and ciprofloxacin)
were placed and gently pressed down on the surface of
the agar plates. Plates were then incubated aerobically
for 18–24 h at 37˚C, after that zones of inhibition were
measured and recorded. The results were used to determine the isolates as sensitive, intermediate, and resistant
according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [37].
Measurement of Minimum Inhibitory Concentration (MIC)

Agar dilution method outlined in CLSI document
M100-S24 (2014) [37] was performed to determine MIC
of each isolate. Ten different antibiotics (oxacillin, vancomycin, penicillin, tetracycline, clindamycin, chloramphenicol, erythromycin, cotrimoxazole, gentamycin and
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ciprofloxacin) were diluted to concentration ranging
from 1.25 µg/ml to 5120 µg/ml. Appropriate dilutions of
antibiotics were added to molten Mueller Hinton agar
and poured into sterile petri dishes. To solidified media,
5 µl of 1:10 diluted 0.5 McFarland standard bacterial suspensions were spot inoculated. After 24 h of incubation
at 35 °C, isolates were categorized based on their breakpoints for resistance according to the recommendations
by CLSI [37].
Persister assay

Persister assay was performed for 60 selected staphylococcal clinical isolates representing 10 susceptible
isolates for six antibiotics tested. Overnight bacterial
cultures were prepared by inoculating frozen cells into
5 ml of TSB in 50 ml culture tubes, incubated at 37 °C in
incubator shaker at 225 rpm. The overnight cultures were
diluted 1:10 in fresh TSB medium, incubated further for
2 h and normalized to an optical density at O
 D600 of 0.05
in pre-warmed 10 ml TSB in 125 ml conical flask to use
as starting culture. The starting bacterial cultures were
grown ~ 2 h until they reached an O
 D600 of 0.5–0.6 and
16 h for exponential phase culture and stationary phase
cultures respectively. Persister assay was performed in
both the exponential and stationary phase staphylococcal cells. When the culture reached at exponential
phase, 100 μl of the culture was taken, serially diluted
and spread on the surface of TSA plates to determine the
initial colony forming units (CFUs) count. The remaining cultures were challenged with 20 × MIC of individual
antibiotics and further incubated at 37 °C with continuous shaking (225 rpm). At designated time points after
antibiotic exposure, 100 μl of bacterial suspension was
taken, washed with PBS and serially diluted. After that,
10 μl cell suspensions were spotted onto TSA plates and
incubated for 24 h for persister count. Same procedure
was followed for persister assay in stationary phase culture using 100 × MIC of individual antibiotics.
Statistical analysis

Results for antibiotic susceptibility were expressed in
terms of MIC-50 and MIC-90 to represent that of 50%
and 90% of the bacterial growth inhibition respectively.
The Chi-square test was used to evaluate the statistical significance of differences in the results. The p value
of < 0.05 was considered statistically significant.
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